'Substance P' in tears—a noninvasive test for diabetes-related nerve damage?

July 5, 2017, Wolters Kluwer Health

Levels of a nerve cell signaling molecule called substance P—measured in tear samples—might be a useful marker of diabetes-related nerve damage (neuropathy), suggests a study in the July issue of Optometry and Vision Science, the official journal of the American Academy of Optometry.

Tear samples from patients with diabetes show elevated levels of substance P, which are related to early damage to the corneal nerves, which may contribute to the development of corneal ulcers and poor wound healing in patients with diabetes, according to the pilot study by Maria Markoulli, PhD, MOptom, FAAO, and colleagues of University of New South Wales, Sydney, Australia. They researchers suggest that substance P measurement could be a new and noninvasive test to assess the risk of diabetic neuropathy.

Substance P in Tears a 'Potential Biomarker of Corneal Nerve Health'

The researchers measured substance P levels in the natural tear film in the eyes of nine adults with diabetes and a control group of 17 nondiabetic subjects. Substance P is a neuropeptide that contributes to wound healing, among other functions. Substance P is also involved in maintenance and nutrition of the cornea—the clear, outermost layer of the eye. The cornea has a rich network of fine nerves, which play critical roles in protecting and healing the surface of the eye.

Unlike nerves elsewhere in the body, the structure of the living corneal nerve can be seen and measured using a technique called confocal microscopy. Studies have shown that corneal nerve fiber density, measured by confocal microscopy, can predict diabetes-related damage to the peripheral nerves, called peripheral neuropathy.

This common diabetes complication causes symptoms including pain and numbness of the hands and feet. Damage to the peripheral nerves can be seen on biopsy samples, but this is an invasive and nonrepeatable procedure. Dr. Markoulli and colleagues sought to determine whether substance P levels in tears reflect damage to the corneal nerves in diabetic patients.

The results showed that patients with diabetes had substantially lower levels of substance P in tear film samples, compared to healthy controls.

On confocal microscopy, the diabetic patients also had a significantly lower corneal nerve fiber density, indicating loss of corneal nerve fibers. Substance P levels were "moderately" correlated with the corneal nerve fiber density measurements.

"The positive correlation between substance P and corneal nerve density indicates that substance P may be a potential biomarker for corneal health," Dr. Markoulli and coauthors write. In the eyes, reduced levels of substance P might contribute to poor wound healing and the development of in patients with diabetes. That's consistent with recent studies reporting that substance P derivatives can promote healing of diabetes-related corneal defects.

In the future, measuring substance P levels in the tear film might become a useful, noninvasive test for assessing the risk of peripheral neuropathy in with . Dr. Markoulli and colleagues emphasize that further research is needed—including studies to confirm whether substance P reflects the presence or absence of peripheral neuropathy.

Explore further: Reduced corneal nerve fiber density in patients with HIV

More information: Maria Markoulli et al. Corneal Nerve Morphology and Tear Film Substance P in Diabetes, Optometry and Vision Science (2017). DOI: 10.1097/OPX.0000000000001096

Related Stories

Reduced corneal nerve fiber density in patients with HIV

June 12, 2017
(HealthDay)—Patients with HIV and HIV-associated sensory neuropathy (HIV-SN) have reduced corneal nerve fiber density, which can be identified using in vivo corneal confocal microscopy (IVCCM), according to a study published ...

Research suggests seal oil could help people with Type 1 diabetes

June 13, 2017
A research team at the Krembil Neuroscience Centre in Toronto has published a paper that suggests seal oil has the potential to help promote nerve regeneration in patients with Type 1 diabetes.

Omega-3 essential fatty acids may protect corneal nerves in dry eye

March 21, 2017
(HealthDay)—Oral, long-chain omega-3 (ω-3) essential fatty acid (EFA) supplementation is neuroprotective to corneal nerves for patients with dry eye disease, according to a study published online March 12 in Ophthalmic ...

New research sets stage for noninvasive monitoring of HIV-induced peripheral neuropathy

May 12, 2014
Corneal nerve fiber assessment has great potential as a tool to diagnose and monitor peripheral neuropathy induced by HIV, say scientists at the Johns Hopkins University School of Medicine. The results of their study are ...

Study provides new understanding of diabetic peripheral neuropathy

April 11, 2016
A research team from Wayne State University recently published a paper in the Journal of Clinical Investigation that provides a paradigm shift in the understanding of cellular and molecular mechanisms underlying diabetic ...

Substances found in cornea activate healing of blinding scar tissue

December 18, 2015
Doctoral student Marta Słoniecka at the Department of Integrative Medical Biology has found that the neuropeptide substance P and the neurotransmitter acetylcholine activate and enhance healing of the cornea. The two substances ...

Recommended for you

Researchers are one step closer to developing eye drops to treat age-related macular degeneration

July 19, 2018
Scientists at the University of Birmingham are one step closer to developing an eye drop that could revolutionise treatment for age-related macular degeneration (AMD).

An orange a day keeps macular degeneration away: 15-year study

July 12, 2018
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Injectable electronics offer powerful new tool in understanding how retinal cells work

June 28, 2018
Charles Lieber and his group are rewriting the rules of how scientists study retinal cells, and they're doing it with a single injection.

Why the eye could be the window to brain degeneration such as Alzheimer's disease

June 26, 2018
Researchers from Queen's University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer's disease (AD).

Microglia protect sensory cells needed for vision after retinal detachment

June 18, 2018
A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment. Retinal detachment and subsequent degeneration ...

161 genetic factors for myopia identified

June 15, 2018
The international Consortium for Refractive Error and Myopia (CREAM) recently published the largest-ever genetic study of myopia in Nature Genetics. Researchers from the Gutenberg Health Study at the Medical Center of Johannes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.